NYSE:MET - Metlife Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $44.87 -0.44 (-0.97 %) (As of 01/22/2019 04:00 PM ET)Previous Close$45.31Today's Range$44.6050 - $45.1952-Week Range$37.76 - $55.21Volume5.70 million shsAverage Volume5.38 million shsMarket Capitalization$44.28 billionP/E Ratio9.97Dividend Yield3.73%Beta1.21 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability, as well as small business owners' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. MetLife, Inc. has a strategic alliance with Ernst & Young LLP. The company serves individuals, corporations and their employees, and other institutions through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and other organizations, as well as through career agency, bancassurance, direct marketing, brokerage, and other third-party distribution and e-commerce channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York. Receive MET News and Ratings via Email Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Life insurance Sub-IndustryLife & Health Insurance SectorFinance Current SymbolNYSE:MET Previous Symbol CUSIP59156R10 Webwww.metlife.com Phone212-578-9500Debt Debt-to-Equity Ratio0.28 Current Ratio0.14 Quick Ratio0.14Price-To-Earnings Trailing P/E Ratio9.97 Forward P/E Ratio8.42 P/E Growth0.61 Sales & Book Value Annual Sales$62.09 billion Price / Sales0.71 Cash Flow$4.4338 per share Price / Cash Flow10.12 Book Value$55.94 per share Price / Book0.80Profitability EPS (Most Recent Fiscal Year)$4.50 Net Income$4.01 billion Net Margins7.62% Return on Equity9.76% Return on Assets0.76%Miscellaneous Employees49,000 Outstanding Shares986,838,000Market Cap$44.28 billion OptionableOptionable Metlife (NYSE:MET) Frequently Asked Questions What is Metlife's stock symbol? Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET." How often does Metlife pay dividends? What is the dividend yield for Metlife? Metlife announced a quarterly dividend on Monday, January 7th. Stockholders of record on Tuesday, February 5th will be given a dividend of $0.42 per share on Wednesday, March 13th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 3.74%. The ex-dividend date of this dividend is Monday, February 4th. View Metlife's Dividend History. How will Metlife's stock buyback program work? Metlife announced that its board has approved a share buyback plan on Thursday, November 1st 2018, which authorizes the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 4.6% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's management believes its stock is undervalued. How were Metlife's earnings last quarter? Metlife Inc (NYSE:MET) released its earnings results on Thursday, November, 1st. The financial services provider reported $1.38 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.27 by $0.11. The financial services provider had revenue of $16.40 billion for the quarter, compared to the consensus estimate of $15.88 billion. Metlife had a net margin of 7.62% and a return on equity of 9.76%. The business's revenue for the quarter was down 2.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.09 EPS. View Metlife's Earnings History. When is Metlife's next earnings date? Metlife is scheduled to release their next quarterly earnings announcement on Wednesday, February 6th 2019. View Earnings Estimates for Metlife. How can I listen to Metlife's earnings call? Metlife will be holding an earnings conference call on Thursday, February 7th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8002301085. What price target have analysts set for MET? 13 brokerages have issued twelve-month price objectives for Metlife's stock. Their predictions range from $44.06 to $63.00. On average, they expect Metlife's share price to reach $53.5050 in the next year. This suggests a possible upside of 19.2% from the stock's current price. View Analyst Price Targets for Metlife. What is the consensus analysts' recommendation for Metlife? 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Metlife. What are Wall Street analysts saying about Metlife stock? Here are some recent quotes from research analysts about Metlife stock: 1. According to Zacks Investment Research, "MetLife has been performing significantly well on the back of prudent underwriting and expense management. Its efforts to streamline business, only to focus on core business are really impressive. Its revenues grew in 2017 and first half of 2018 after declining for two years and the trend is likely to continue. Its strong international operations and disciplined capital management should drive long-term growth. Its shares have outperformed its industry in six months time. However, the company’s exposure to catastrophe losses and investment in efficiency programs will put pressure on margins. Shares of the company have lost in a year’s time, slightly narrower than its industry’s decline." (1/21/2019) 2. Wells Fargo & Co analysts commented, "We attended in Tokyo. The company provided context around its Asian business, which represents 25% of its earnings ($1.2 billion in 2017) but is expected to grow in the double-digits. Of its Asian business about 75% of its earnings comes from Japan. MET spoke optimistically about: (1) the growth prospects of the region due to its low insurance penetration, GDP growth of 4.8% in the countries MET operates in, and an aging population, and (2) its commitment to sustainable growth in cash from its Asian business (60% of its GAAP earnings are being taken out as dividends). The meeting also gave us a chance to hear from Kishore Ponnavolu, who took over as head of MET’s Asian business at the start of September. We are not changing our EPS estimates or price target at this time and do not expect a material movement in the shares following the meeting." (9/27/2018) Has Metlife been receiving favorable news coverage? News coverage about MET stock has trended very positive this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Metlife earned a media sentiment score of 3.2 on InfoTrie's scale. They also assigned media headlines about the financial services provider a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days. Who are some of Metlife's key competitors? Some companies that are related to Metlife include China Life Insurance (LFC), AXA (AXAHY), Prudential Public (PUK), Prudential Financial (PRU), SWISS RE LTD/S (SSREY), Manulife Financial (MFC), Sun Life Financial (SLF), AVIVA PLC/ADR (AVVIY), HANNOVER RUECK/S (HVRRY), AEGON (AEG), Lincoln National (LNC), Reinsurance Group of America (RGA), Torchmark (TMK), Scor (SCRYY) and Athene (ATH). Who are Metlife's key executives? Metlife's management team includes the folowing people: Mr. Steven Albert Kandarian, Chairman, Pres & CEO (Age 66)Mr. Martin J. Lippert, Exec. VP and Head of Global Technology & Operations (Age 59)Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 60)Mr. Michel A. Khalaf, Pres of U.S. Bus. & EMEA (Age 55)Mr. John Dennis McCallion, Exec. VP & CFO (Age 45) Who are Metlife's major shareholders? Metlife's stock is owned by many different of retail and institutional investors. Top institutional investors include Douglas Lane & Associates LLC (0.13%), RNC Capital Management LLC (0.07%), Ferguson Wellman Capital Management Inc. (0.04%), CHURCHILL MANAGEMENT Corp (0.04%), Lodestar Investment Counsel LLC IL (0.04%) and Klingenstein Fields & Co. LLC (0.04%). Company insiders that own Metlife stock include Carlos M Gutierrez, Christopher G Townsend, Gerald L Hassell, James M Kilts and Steven A Kandarian. View Institutional Ownership Trends for Metlife. Which institutional investors are selling Metlife stock? MET stock was sold by a variety of institutional investors in the last quarter, including RNC Capital Management LLC, Gulf International Bank UK Ltd, Steward Partners Investment Advisory LLC, Douglas Lane & Associates LLC, 6 Meridian, GW Henssler & Associates Ltd., James Investment Research Inc. and Klingenstein Fields & Co. LLC. View Insider Buying and Selling for Metlife. Which institutional investors are buying Metlife stock? MET stock was bought by a variety of institutional investors in the last quarter, including CHURCHILL MANAGEMENT Corp, Ferguson Wellman Capital Management Inc., DNB Asset Management AS, Nisa Investment Advisors LLC, Weather Gauge Advisory LLC, Benson Investment Management Company Inc., Verity & Verity LLC and Rockland Trust Co.. Company insiders that have bought Metlife stock in the last two years include Carlos M Gutierrez, Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife. How do I buy shares of Metlife? Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Metlife's stock price today? One share of MET stock can currently be purchased for approximately $44.87. How big of a company is Metlife? Metlife has a market capitalization of $44.28 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe. What is Metlife's official website? The official website for Metlife is http://www.metlife.com. How can I contact Metlife? Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500. MarketBeat Community Rating for Metlife (NYSE MET)Community Ranking: 3.1 out of 5 ( )Outperform Votes: 760 (Vote Outperform)Underperform Votes: 480 (Vote Underperform)Total Votes: 1,240MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/22/2019 by MarketBeat.com StaffFeatured Article: What are trading strategies for the 52-week high/low?